BridgeMD
New treatment option for Preterm Children
Official title Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".
ClinicalTrials.gov ID: NCT04945369
What this study is testing
- What it's testing
- Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood. It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 14
You may be able to join if
- Children hospitalised at the Nantes University Hospital in the neonatal period
- With a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol
- Born prematurely (under 35 weeks of amenorrhea)
- Included in the Lift cohort with follow-up up to 7 years
- Aged between 8 and 14 years at inclusion
You likely can't join if
- Children with an isolated metabolic disease: insulin-dependent diabetes; endocrine disease (Cushing's, hypothyroidism)
- Age of 15 years or more
- with a chromosomal anomaly
- with contraindicating measurement of the BOP-POD: ventilatory support, continuous parenteral feeding, elimination stoma
- Refusal of either parent or child
The study team makes the final eligibility decision.
Where it's taking place
- Nantes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 14 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.